GlobeNewsWire
18 Jun 2026, 21:30 UTC · 2h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
3 claims · each scored for market impact
GeneDx Holdings Corp. (WGS) recorded a $31.3 million impairment loss related to its acquisition of Fabric Genomics. — A massive write-down shortly after acquisition indicates a failure in due diligence or a significant collapse in the asset's value, severely impacting the balance sheet.
-0.80GeneDx reported a drop in adjusted gross margins, lowered projected earnings, and lower-than-expected average reimbursement rates in Q1 2026. — These fundamental operational headwinds suggest systemic profitability issues beyond a single failed acquisition.
-0.70A securities fraud class action lawsuit has been filed against GeneDx alleging misleading statements regarding the viability of Fabric Genomics. — Legal action introduces significant regulatory risk and potential future financial liabilities through settlements.
-0.50Which stocks this story touches
Continue reading
6 related stories
Top 3 movers · tap to explore
The company is facing a securities fraud class action lawsuit following a 49% stock drop and a significant impairment loss related to an acquisition.
The company is the subject of a securities fraud class action lawsuit.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Newsfile Corp
3h ago
